Structure and function of natural killer cell receptors: Multiple molecular solutions to self, nonself discrimination

Annual Review of Immunology

Volumn 20, Issue , 2002, Pages 853-885

  Natarajan, Kannan ^a   Dimasi, Nazzareno ^a   Wang, Jian ^a   Mariuzza, Roy A ^a   Margulies, David H ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Inhibitory and activating receptors; Missing self; Natural killer (NK) cells; NK receptors; T cell receptors (TCR), MHC, MICA, RAE 1, ULBP

Indexed keywords

CD158 ANTIGEN; CD94 ANTIGEN; IMMUNOGLOBULIN; LECTIN; LEUKOCYTE ANTIBODY; LEUKOCYTE IMMUNOGLOBULIN LIKE RECEPTOR 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR; PROTEIN MICA; PROTEIN RAE 1; PROTEIN ULBP; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ALLELE; AMINO ACID SEQUENCE; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; BINDING SITE; CELL SURFACE; CONFORMATIONAL TRANSITION; CRYSTALLOGRAPHY; GENOME; IMMUNE SYSTEM; LIGAND BINDING; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR DYNAMICS; MOLECULAR RECOGNITION; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ALLELES; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD94; ANTIGENS, LY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; LECTINS, C-TYPE; MACROMOLECULAR SUBSTANCES; MEMBRANE GLYCOPROTEINS; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; RECEPTORS, IMMUNOLOGIC; SELF TOLERANCE; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION;

EID: 0036214286     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.20.100301.064812     Document Type: Review

References (182)

1. The immunoglobulin superfamily-domains for cell surface recognition
2. Biology of animal lectins
3. The C-type lectin superfamily in the immune system
4. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
5. In search of the 'missing self': MHC molecules and NK cell recognition
6. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy
7. Host resistance directed selectively against H-2-deficient lymphoma variants. Analysis of the mechanism
8. Demonstration by class I gene transfer that reduced susceptibility of human cells to natural killer cell-mediated lysis is inversely correlated with HLA class I antigen expression
9. Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes
10. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells
11. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells
12. Transgenic expression of the Ly49A natural killer cell receptor confers class I major histocompatibility complex (MHC)-specific inhibition and prevents bone marrow allograft rejection
13. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells
14. A murine T lymphocyte antigen belongs to a supergene family of type II integral membrane proteins
15. NK cell receptors
16. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis
17. Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F1 hybrid mice
18. Peculiar immunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice
19. Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection
20. The role of Ly49A and 5E6(Ly49C) molecules in hybrid resistance mediated by murine natural killer cells against normal T cell blasts
21. On guard-activating NK cell receptors
22. Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes
23. CD69-mediated pathway of lymphocyte activation: Anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta
24. CD44 triggering enhances human NK cell cytotoxic functions
25. cDNA cloning of mouse NKR-P1 and genetic linkage with LY-49. Identification of a natural killer cell gene complex on mouse chromosome 6
26. Activation of cytolytic T lymphocyte and natural killer cell function through the T11 sheep erythrocyte binding protein
27. A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells
28. Cutting edge: Human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP
29. DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes
30. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells
31. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily
32. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis
33. p46, a novel natural killer cell-specific surface molecule that mediates cell activation
34. Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells
35. Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1
36. Purified lymphocyte function-associated antigen 3 binds to CD2 and mediates T lymphocyte adhesion
37. Affinity and kinetic analysis of the interaction of the cell adhesion molecules rat CD2 and CD48
38. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48
39. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells
40. Cumulative inhibition of NK cells and T cells resulting from engagement of multiple inhibitory Ly49 receptors
41. Opposing functions of activatory T-cell receptors and inhibitory NK-cell receptors on cytotoxic T cells
42. Inhibitory MHC class I receptors on NK cells and T cells
43. HLA-class I-specific inhibitory receptors of NK type on a subset of human T cells
44. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing
45. DC-SIGN, a dentritic cell-specific HIV-1 receptor present in placenta that infects T cells in trans-a review
46. Cloning of human DECTIN-1, a novel C-type lectin-like receptor gene expressed on dendritic cells
47. Identification of a novel, dendritic cell-associated molecule, dectin-1, by subtractive cDNA cloning
48. Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors
49. Crystal structure of the HLA-Cw3 allotype-specific killer cell inhibitory receptor KIR2DL2
50. Crystal structure of the human p58 killer cell inhibitory receptor (KIR2DL3) specific for HLA-Cw3-related MHC class I
51. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand
52. Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex
53. Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2)
54. Structure of CD94 reveals a novel C-type lectin fold: Implications for the NK cell-associated CD94/NKG2 receptors
55. Crystal structure of human CD69: A C-type lectin-like activation marker of hematopoietic cells
56. Crystal structure of the C-type lectin-like domain from the human hematopoietic cell receptor CD69
57. Crystal structure of the murine NK cell-activating receptor NKG2D at 1.95 A
58. Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand
59. Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA
60. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains
61. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor
62. Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C
63. Regulation of immune responses through inhibitory receptors
64. DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells
65. Gene structure, expression pattern, and biological activity of mouse killer cell activating receptor-associated protein (KARAP)/DAP-12
66. An activating immunoreceptor complex formed by NKG2D and DAP10
67. Cutting edge: KAP10, a novel transmembrane adapter protein genetically linked to DAP12 but with unique signaling properties
68. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function
69. Phenotypic and cytokine analysis of human peripheral blood gamma delta T cells expressing NK cell receptors
70. Killer cell inhibitory receptor expression by T cells
71. Specificity of HLA class I antigen recognition by human NK clones: Evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type
72. Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer
73. Human natural killer cell inhibitory receptors bind to HLA class I molecules
74. Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-Cw4 class I major histocompatibility complex molecule
75. The binding site of NK receptors on HLA-C molecules
76. Kinetics of interaction of HLA-C ligands with natural killer cell inhibitory receptors
77. Interaction between the human NK receptors and their ligands
78. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80
79. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor
80. Threonine 80 on HLA-B27 confers protection against lysis by a group of natural killer clones
81. Binding of a soluble p70 killer cell inhibitory receptor to HLA-B*5101: Requirement for all three p70 immunoglobulin domains
82. A human killer inhibitory receptor specific for HLA-A1,2
83. The natural killer cell receptor specific for HLA-A allotypes: A novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer
84. Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules
85. Peptide specificity in the recognition of MHC class I by natural killer cell clones
86. Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules
87. The immunoglobulin fold. Structural classification, sequence patterns and common core
88. Human growth hormone and extracellular domain of its receptor: Crystal structure of the complex
89. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation
90. The X-ray structure of a growth hormone-prolactin receptor complex
91. Crystal structure at 2.8 Å resolution of a soluble form of the cell adhesion molecule CD2
92. Structures of an HIV and MHC binding fragment from human CD4 as refined in two crystal lattices
93. Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains
94. A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes
95. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition
96. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2
97. Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids
98. An alpha-beta T cell receptor structure at 2.5 Å and its orientation in the TCR-MHC complex
99. The structure, organization, activation and plasticity of the erythropoietin receptor
100. Structural basis of T cell recognition
101. The crystal structure of a T cell receptor in complex with peptide and MHC class II
102. Structure of a covalently stabilized complex of a human alphabeta T-cell receptor, influenza HA peptide and MHC class II molecule, HLA-DR1
103. Shape complementarity at protein/protein interfaces
104. Structure of a heterophilic adhesion complex between the human CD2 and CD58 (LFA-3) counterreceptors
105. A functional hot spot for antigen recognition in a superagonist TCR/MHC complex
106. Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical
107. The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity
108. Peptide sequence requirements for the recognition of HLA-B* 2705 by specific natural killer cells
109. Structure of human histocompatibility leukocyte antigen (HLA)-Cw4, a ligand for the KIR2D natural killer cell inhibitory receptor
110. The leukocyte immunoglobulin-like receptors (LIRs): A new family of immune regulators
111. A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules
112. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells
113. A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing
114. Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: Structural evidence for new stimulatory and inhibitory pathways
115. ILT receptors at the interface between lymphoid and myeloid cells
116. Human inhibitory and activating Ig-like receptors which modulate the function of myeloid cells
117. The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes
118. Crystal structure of coagulation factor IX-binding protein from habu snake venom at 2.6 Å implication of central loop swapping based on deletion in the linker region
119. Structure of coagulation factors IX/X-binding protein, a heterodimer of C-type lectin domains
120. Interaction of the low-affinity receptor CD23/Fc epsilonRII lectin domain with the Fc epsilon3-4 fragment of human immunoglobulin E
121. The ice-binding site of sea raven antifreeze protein is distinct from the carbohydrate-binding site of the homologous C-type lectin
122. The solution structure of type II antifreeze protein reveals a new member of the lectin family
123. Crystal structure of human lithostathine, the pancreatic inhibitor of stone formation
124. Collectin structure: A review
125. Structure and function of the macrophage mannose receptor
126. Mannose receptor and scavenger receptor: Two macrophage pattern recognition receptors with diverse functions in tissue homeostasis and host defense
127. Natural killer cells
128. Expression analysis of new Ly49 genes: Most transcripts of Ly49j lack the transmembrane domain
129. Class I MHC-binding characteristics of the 129/j ly49 repertoire
130. Identification of a human member of the Ly-49 multigene family
131. The genomic context of natural killer receptor extended gene families
132. Evolution of natural killer cell receptors: Coexistence of functional Ly49 and KIR genes in baboons
133. The natural killer cell receptor Ly-49A recognizes a peptide-induced conformational determinant on its major histocompatibility complex class I ligand
134. Host MHC class I molecules modulate in vivo expression of a NK cell receptor
135. d: Identification of a site distinct from the TCR site
136. Biophysical studies of T-cell receptors and their ligands
137. Interactions of TCRs with MHC-peptide complexes: A quantitative basis for mechanistic models
138. A three-domain T cell receptor is biologically active and specifically stains cell surface MHC/peptide complexes
139. Molecular characterization of human CD94: A type II membrane glycoprotein related to the C-type lectin superfamily
140. Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: Association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases
141. Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells
142. Association of DAP12 with activating CD94/NKG2C NK cell receptors
143. CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells
144. NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor
145. HLA-E is the ligand for the natural killer cell CD94/NKG2 receptors
146. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1 (b)
147. Qa-1b binds conserved class I leader peptides derived from several mammalian species
148. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9
149. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis
150. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
151. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
152. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells
153. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E
154. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
155. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB
156. Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells
157. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium
158. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor
159. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice
160. Ligands for the murine NKG2D receptor: Expression by tumor cells and activation of NK cells and macrophages
161. Rael and H60 ligands of the NKG2D receptor stimulate tumour immunity
162. Structure of the C-type lectin carbohydrate recognition domain of human tetranectin
163. Crystal structure of tetranectin, a trimeric plasminogen-binding protein with an alpha-helical coiled coil
164. Activating and inhibitory NK cell receptors
165. The structure of a tunicate C-type lectin from Polyandrocarpa misakiensis complexed with D-galactose
166. The atomic structure of protein-protein recognition sites
167. Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2
168. Structural basis of CD8 coreceptor function revealed by crystallographic analysis of a murine CD8alphaalpha ectodomain fragment in complex with H-2Kb
169. NK cell receptors: Of missing sugar and missing self
170. NK and CTL recognition of a single chain H-2Dd molecule: Distinct sites of H-2Dd interact with NK and TCR
171. Mapping the ligand of the NK inhibitory receptor Ly49A on living cells
172. The functional binding site for the C-type lectin-like natural killer cell receptor Ly49A spans three domains of its major histocompatibility complex class I ligand
173. d and β2-m
174. Recognition of class I major histocompatibility complex molecules by Ly-49: Specificities and domain interactions
175. Crystal structure of the MHC class I homolog MIC-A, a gammadelta T cell ligand
176. Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E
177. Analysis of Qa-1(b) peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes
178. Paired immunoglobulin-like receptors of activating and inhibitory types
179. Biochemical nature and cellular distribution of the paired immunoglobulin-like receptors, PIR-A and PIR-B
180. New nomenclature for MHC receptors
181. Structure of the calcium-dependent lectin domain from a rat mannose-binding protein determined by MAD phasing
182. ESPript: Analysis of multiple sequence alignments in PostScript